What should be the future direction of development in the field of prostate cancer with lung metastasis?
Zhi‐Guang Huang(Lincoln University), Juan He, Gang Chen(Fudan University), Yi Chen(Sun Yat-sen University), Xiao Feng(University of Science and Technology of China), Tong Wu(Jiangsu University), Dongming Li(Dalian University), Bin-Tong Yin(First Affiliated Hospital of GuangXi Medical University), Shenghua Li(Huaihua University), Jiwen Cheng(Guangxi Medical University)
Cited by 3
Related Papers
FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets
|The Oncologist|2003|576
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
|PubMed|2002|469